Chinese stocks close lower; AI drug discovery, auto, agriculture sectors surge on news catalysts
Chinese stock markets closed slightly lower on September 17, with the Shanghai Composite falling 0.36%, the Shenzhen Component dropping 0.29%, and the ChiNext Index declining 0.12%. Morning session turnover reached 1.24 trillion yuan, up 79.5 billion yuan from the previous session. Sector rotation was rapid, with innovative drug and CXO concept stocks surging after GenScript Biotech announced a collaboration with Eli Lilly's AI drug discovery platform. The automotive sector rose after GAC Group announced plans to acquire equity from FAW Co., Ltd. Agriculture stocks gained following the release of a digital village development plan. Over 3,100 stocks declined.
IllustrationEditorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page reads the event directly, while its address stays stable when the title changes.
- Summary covers the current reports
Cross-source coverage
Reporting timeline
China's AI Application Stocks Surge, Semiconductor Chips Active as Market Turns Over
Chinese A-share markets saw mixed trading on September 22, with the ChiNext index initially surging over 2% before paring gains to close nearly 1% higher. The Shanghai Composite traded in positive territory. Total turnover for the morning session reached 1.43 trillion yuan, up 100.4 billion from the previous session. AI application concept stocks led gains, with companies like Nanwei Software, Zhidu Shares, and Guangyun Technology rising. The sector was boosted by Meta's early-September launch of a consumer AI agent. Semiconductor chip stocks, including computing and end-side chips, were also active. CXO concept stocks strengthened again, driven by a partnership between Eli Lilly and Genscript Biotech, which is expected to increase AI-driven drug development orders. Alibaba CEO Wu Yongming stated at the Apsara Conference that the company will fully invest in AI infrastructure, targeting over 20GW of global data center capacity by 2032. Pingtouge also announced a significant increase in annual shipments of its domestic AI chips. The market is viewed as trending upward with opportunities for dips in hot sectors.
Read sourceChina Stocks Close Lower; AI Drug Discovery, Auto, Agriculture Sectors Active
Chinese stock markets closed slightly lower on September 17, with the Shanghai Composite Index falling 0.36%, the Shenzhen Component Index down 0.29%, and the ChiNext Index down 0.12%. Combined morning trading volume reached 1.24 trillion yuan, up 79.5 billion yuan from the previous session. The innovative drug and CXO sectors surged following GenScript Biotech's announcement of a collaboration with Eli Lilly's AI/machine learning drug discovery platform, LiLLY TuneLab. Zheshang Securities commented that AI-driven drug discovery has moved from the 'algorithm narrative' to the 'clinical realization' phase. The automotive sector rose after GAC Group announced plans to acquire equity from FAW Co., Ltd., making FAW its second-largest shareholder. The agricultural sector was active after the Cyberspace Administration of China and other ministries issued a digital village action plan for 2026-2030. The tourism sector also gained following a cultural and tourism development plan. Precious metals concepts declined. Market sentiment is recovering with increasing trading volume, though sector rotation remains rapid.
Read sourceChina Stocks End Mixed; AI Drug Discovery, Auto, Agriculture Sectors Lead Gains
China's three major stock indices closed slightly lower on September 17 after a volatile morning session, with the Shanghai Composite down 0.36%, the Shenzhen Component down 0.29%, and the ChiNext Index down 0.12%. Turnover on the Shanghai and Shenzhen exchanges reached 1.24 trillion yuan in the first half, up 79.5 billion yuan from the previous session. Innovative drug and CXO concept stocks surged, led by Jinshi Yaoye, Baihua Pharmaceutical, and Nanhua Biotech, following GenScript Biotech's collaboration with Eli Lilly's AI drug discovery platform LiLLY TuneLab. Zheshang Securities noted that AI-driven drug discovery has entered the clinical realization phase. The automotive sector saw sudden gains after GAC Group announced plans to acquire equity from FAW Co., Ltd., making FAW its second-largest shareholder. Agricultural stocks rose on the release of the Action Plan for High-Quality Development of Digital Villages (2026-2030). The tourism sector also performed well following the Ministry of Culture and Tourism's 15th Five-Year Plan. Over 3,100 stocks declined, with precious metals concepts falling. The market maintained a pattern of oscillation and rotation with increasing trading volume.
Read sourceShow 17 older updatesHide older updates
China Stocks Close Lower; Innovative Drugs Surge, Auto and Agriculture Sectors Active
Chinese stock markets ended the morning session slightly lower, with the Shanghai Composite Index falling 0.36%, the Shenzhen Component Index dropping 0.29%, and the ChiNext Index declining 0.12%. Combined turnover reached 1.24 trillion yuan, up 79.5 billion yuan from the previous session. Innovative drug and CXO concept stocks rallied broadly, with Jinshi Yaoye, Baihua Pharmaceutical, and Nanhua Biotech hitting daily limits, following GenScript Biotech's collaboration with Eli Lilly's AI drug discovery platform. Zheshang Securities stated AI-driven drug discovery has moved to the 'clinical realization' stage. The automotive sector saw sudden gains, with Ankai Bus, Haima Automobile, and Zotye Auto hitting daily limits after GAC Group announced plans to acquire equity from FAW Co., Ltd. Agricultural stocks like Jinjian Rice Industry and Dunhuang Seed also hit daily limits following a government action plan for digital village development. The tourism sector performed well after a ministry plan for cultural and tourism development. Market hotspots rotated rapidly, with over 3,100 stocks declining overall.
Read sourceChina Stocks Close Lower; Innovative Drugs Surge on AI Drug Discovery News
Chinese stock markets closed slightly lower on September 17, with the Shanghai Composite Index falling 0.36%, the Shenzhen Component Index dropping 0.29%, and the ChiNext Index declining 0.12%. Combined morning trading volume reached 1.24 trillion yuan, up 79.5 billion yuan from the previous session. Over 3,100 stocks declined. The innovative drug sector surged after GenScript Biotech announced a collaboration with Eli Lilly on its AI/machine learning drug discovery platform, LiLLY TuneLab. Zheshang Securities stated that AI-driven drug discovery has moved from the 'algorithm narrative' to the 'clinical realization' stage. The automotive sector saw unusual upward moves after GAC Group announced plans to acquire equity in a joint venture from FAW Co., Ltd., making FAW its second-largest shareholder. Agriculture stocks rose following the release of a digital village development action plan for 2026-2030. The tourism sector also performed well after the Ministry of Culture and Tourism issued its 15th Five-Year Plan. Market hotspots rotated rapidly, with technology stocks showing internal divergence.
Read sourceChina Stocks Close Lower; Innovative Drugs, Autos, Agriculture Lead Gains
Chinese stock markets closed slightly lower on September 17 after a volatile morning session, with the Shanghai Composite Index falling 0.36%, the Shenzhen Component Index dropping 0.29%, and the ChiNext Index declining 0.12%. Combined turnover reached 1.24 trillion yuan, up 79.5 billion yuan from the previous session. Sector rotation was rapid, with innovative drug and CXO concept stocks surging collectively following GenScript Biotech's collaboration with Eli Lilly's AI drug discovery platform. Zheshang Securities noted AI-driven drug discovery has moved to the 'clinical realization' phase. The automotive sector saw unusual upward momentum after GAC Group announced plans to acquire equity from FAW, making FAW its second-largest shareholder. Agricultural stocks rose following the release of the Action Plan for High-Quality Development of Digital Villages (2026-2030). Tourism stocks also performed well after the Ministry of Culture and Tourism issued its 15th Five-Year Plan. Technology stocks showed internal divergence after leading gains the previous day. Market sentiment is gradually recovering with increasing trading volume.
Read sourceChina Stocks End Lower; Drug, Auto, Agriculture Sectors Rally; Fed Hikes Rates
Chinese stock markets closed slightly lower on September 17, with the Shanghai Composite Index falling 0.36%, the Shenzhen Component Index dropping 0.29%, and the ChiNext Index declining 0.12%. Combined turnover reached 1.24 trillion yuan in the morning session. Sector hotspots rotated rapidly, with innovative drug and CXO concepts rallying broadly after GenScript Biotech announced a collaboration with Eli Lilly's AI drug discovery platform. Zheshang Securities noted AI-driven drug discovery has moved from narrative to clinical realization. The automotive sector surged unexpectedly following GAC Group's announcement of a planned equity acquisition from FAW. Agriculture stocks were active after the government issued a digital village development plan. Tourism stocks also gained on a new cultural and tourism plan. On the downside, precious metals concepts adjusted. Separately, Huawei announced the Ascend 960 chip release is moved up to Q1 2027, and the Federal Reserve raised interest rates by 25 basis points, the first hike since July 2023.
Read sourceChina Stocks Close Lower; Innovative Drugs, Auto, Agriculture Sectors Active
Chinese stock markets ended the morning session slightly lower on September 17, with the Shanghai Composite Index falling 0.36%, the Shenzhen Component Index down 0.29%, and the ChiNext Index declining 0.12%. Trading volume reached 1.24 trillion yuan in the first half, up 79.5 billion yuan from the previous session, though over 3,100 stocks declined. Sector rotation was rapid, with innovative drug and CXO concept stocks surging collectively after GenScript Biotech announced a collaboration with Eli Lilly's AI drug discovery platform. Zheshang Securities stated that AI-driven drug discovery has moved to the 'clinical realization' phase, with efficiency improvements stimulating demand for molecular validation. The automotive sector saw sudden upward movements following GAC Group's announcement of a planned equity acquisition from FAW Co., Ltd. The agriculture sector rebounded after the government issued a digital village development action plan. The tourism sector also performed well following the Ministry of Culture and Tourism's 15th Five-Year Plan. Market sentiment is slowly recovering with increasing trading volumes, and investors are advised to focus on structural opportunities and sector rotation.
Read sourceChina Stocks Fluctuate; Innovative Drugs, Autos, Agriculture Active; Fed Hikes Rates
Chinese stock markets experienced a volatile morning session on September 17, with all three major indices closing slightly lower despite an initial surge. The Shanghai Composite Index fell 0.36%, the Shenzhen Component Index dropped 0.29%, and the ChiNext Index declined 0.12%. Combined turnover reached RMB 1.24 trillion, up from the previous session. Sector rotation was rapid, with innovative drug and CXO concepts rallying broadly after GenScript Biotech announced a collaboration with Eli Lilly's AI drug discovery platform. Zheshang Securities noted that AI-driven drug discovery has entered a 'clinical realization' phase. The automotive sector saw sudden upward momentum following GAC Group's announcement of a planned equity acquisition from FAW. Agricultural stocks were active after the release of a national digital village development plan. Tourism stocks also performed well. Meanwhile, Huawei announced the Ascend 960 chip release has been moved up to Q1 2027. The Federal Reserve raised interest rates by 25 basis points, the first hike since July 2023.
Read sourceChina Stocks Close Lower; AI Drug Discovery, Auto, Agriculture Sectors Rally on News Catalysts
China's three major indices closed slightly lower on September 17 after a morning session of volatile consolidation, with the Shanghai Composite falling 0.36%, the Shenzhen Component dropping 0.29%, and the ChiNext Index declining 0.12%. Combined trading volume reached 1.24 trillion yuan, up 79.5 billion yuan from the previous session. Innovative drug and CXO concept stocks surged collectively after GenScript Biotech announced a collaboration with Eli Lilly's AI/machine learning drug discovery platform, LiLLY TuneLab. Zheshang Securities commented that AI-driven drug discovery has moved to the 'clinical realization' stage, with efficiency gains expected to boost demand for molecular validation. The automotive sector saw unusual upward momentum following GAC Group's announcement of a planned equity acquisition from FAW Co., Ltd. Agriculture stocks rose after the Cyberspace Administration of China and other ministries issued a digital village development action plan. Tourism stocks also performed well following the Ministry of Culture and Tourism's 15th Five-Year Plan. Over 3,100 stocks declined, with precious metals concepts falling. Market hotspots rotated rapidly, but trading volume increased, indicating gradual recovery in sentiment.
Read sourceChina Stocks End Lower; Innovative Drugs Surge on AI Drug Discovery Deal, Auto Sector Active
Chinese equities closed slightly lower on September 17, with the Shanghai Composite falling 0.36%, the Shenzhen Component down 0.29%, and the ChiNext Index losing 0.12%. Morning session trading volume reached 1.24 trillion yuan, up 79.5 billion from the prior day. Innovative drug and CXO stocks surged after GenScript Biotech announced a collaboration with Eli Lilly's AI drug discovery platform, LiLLY TuneLab. Zheshang Securities commented that AI-driven drug discovery has moved from the 'algorithm narrative' to the 'clinical realization' phase. The automotive sector saw unusual upward moves after GAC Group announced plans to acquire equity in a joint venture from FAW Co., Ltd. Agricultural stocks rose following the release of the Action Plan for High-Quality Development of Digital Villages (2026-2030). The tourism sector also gained on the Ministry of Culture and Tourism's 15th Five-Year Plan. Precious metals stocks fell. The report notes rapid sector rotation and a slow recovery in market sentiment.
Read sourceChina Stocks Close Lower; Innovative Drugs, Auto, Agriculture Sectors Active
Chinese stock markets experienced a volatile morning session on September 17, with the three major indices closing slightly lower despite an initial surge. The ChiNext Index briefly rose over 1% before retreating. Half-day trading volume in Shanghai and Shenzhen reached 1.24 trillion yuan, up 79.5 billion yuan from the previous session, with over 3,100 stocks declining. Sector rotation was rapid: innovative drug and CXO concepts strengthened collectively, with Jinshi Yaoye, Baihua Pharmaceutical, and Nanhua Biotech hitting daily limit-ups, following GenScript's collaboration with Eli Lilly's AI drug discovery platform. The automotive sector saw unusual upward movements, with Ankai Bus, Haima Automobile, and Zotye Auto hitting limit-ups after GAC Group announced plans to acquire equity from FAW Co., Ltd. The agriculture sector remained active, with Jinjian Rice Industry and Dunhuang Seed hitting limit-ups, supported by a new digital village action plan. Precious metals concepts declined. Separately, Huawei's Wang Tao announced the Ascend 960 chip release was moved up to Q1 2027, and the Federal Reserve raised interest rates by 25 basis points to 3.75%-4.00%, the first hike since July 2023.
Read sourceChina Stocks End Mixed; AI Drug Stocks Surge on GenScript-Eli Lilly Deal, Auto Sector Active
China's three major stock indices closed slightly lower on September 17 after a volatile morning session, with the Shanghai Composite down 0.36%, the Shenzhen Component down 0.29%, and the ChiNext Index down 0.12%. Half-day trading volume on the Shanghai and Shenzhen exchanges reached 1.24 trillion yuan, up 79.5 billion yuan from the previous session. The innovative drug and CXO sectors rallied broadly after GenScript Biotech announced a collaboration with Eli Lilly using its AI/machine learning drug discovery platform LiLLY TuneLab. Zheshang Securities noted that AI-driven drug development has entered the 'clinical realization' phase, with wet-lab experiments being a key bottleneck. The automotive sector saw sudden upward momentum after GAC Group announced plans to acquire equity from FAW Co., making FAW its second-largest shareholder. Agricultural stocks rose following the release of the Digital Village Development Action Plan (2026-2030) by Chinese regulators. The tourism sector also performed well after the Ministry of Culture and Tourism issued its 15th Five-Year Plan. Over 3,100 stocks declined, with precious metals concepts falling. The market maintained a rotation pattern with gradually increasing trading volumes.
Read sourceChina Stocks Close Lower; Innovative Drugs Surge on AI Drug Discovery News
Chinese stock markets closed slightly lower on September 17, with the Shanghai Composite Index falling 0.36%, the Shenzhen Component Index dropping 0.29%, and the ChiNext Index declining 0.12%. Combined turnover reached 1.24 trillion yuan in the morning session, up 79.5 billion yuan from the previous day. Innovative drug and CXO concept stocks rallied broadly after GenScript Biotech announced a collaboration with Eli Lilly's AI drug discovery platform, LiLLY TuneLab. Zheshang Securities stated that AI-driven drug discovery has moved to the 'clinical realization' stage, with wet-lab experiments being the bottleneck, and efficiency improvements from AI will spur demand for molecular validation. The automotive sector saw sudden gains after GAC Group announced plans to acquire equity from FAW Co., Ltd. The agricultural sector was active following the release of the Action Plan for High-Quality Development of Digital Villages (2026-2030). The tourism sector also performed well after the Ministry of Culture and Tourism issued its 15th Five-Year Plan. Over 3,100 stocks declined, with precious metals concepts falling. The market remains in a rotation and consolidation pattern with increasing trading volume.
Read sourceChina Stocks Close Lower; Innovative Drugs Surge, Auto and Agriculture Sectors Active
Chinese stock markets experienced oscillating consolidation in the morning session on September 17, with all three major indices closing slightly lower. The Shanghai Composite fell 0.36%, the Shenzhen Component fell 0.29%, and the ChiNext fell 0.12%. Trading volume reached 1.24 trillion yuan, up 79.5 billion yuan from the previous session. Innovative drug and CXO concept stocks surged collectively, driven by GenScript Biotech's collaboration with Eli Lilly on an AI drug discovery platform. Zheshang Securities noted AI-driven drug discovery has moved to the 'clinical realization' phase. The automotive sector saw unusual upward movements after GAC Group announced plans to acquire equity from FAW Co., Ltd. The agricultural sector remained active following the release of a digital village action plan. The tourism sector also performed well amid a new culture and tourism development plan. Over 3,100 stocks declined across the market. The Federal Reserve raised interest rates by 25 basis points, the first hike since July 2023. Huawei announced the Ascend 960 chip release moved up to Q1 2027.
Read sourceChina Stocks Close Lower; Innovative Drugs, Auto, Agriculture Sectors Active; Fed Hikes Rates
Chinese stock markets experienced oscillating consolidation in the morning session, with the three major indices closing slightly lower. The Shanghai Composite Index fell 0.36%, the Shenzhen Component Index fell 0.29%, and the ChiNext Index fell 0.12%. Trading volume reached 1.24 trillion yuan, an increase of 79.5 billion yuan from the previous session. Sector hotspots rotated rapidly, with innovative drug and CXO concepts surging collectively, driven by a collaboration between GenScript Biotech and Eli Lilly's AI drug discovery platform. Zheshang Securities stated that AI-driven drug discovery has moved to the 'clinical realization' phase. The automotive sector saw unusual upward movements following GAC Group's announcement of a potential equity acquisition from FAW Co., Ltd. The agriculture sector was active after the release of a national digital village development plan. The tourism sector also performed well. On the macro front, the Federal Reserve raised interest rates by 25 basis points, the first hike since July 2023. Additionally, Huawei announced the Ascend 960 chip release has been moved up to Q1 2027.
Read sourceChina Stocks Close Lower; Innovative Drugs Surge, Auto and Agriculture Active
Chinese stock markets closed slightly lower on September 17 after a volatile morning session, with the Shanghai Composite Index falling 0.36%, the Shenzhen Component Index dropping 0.29%, and the ChiNext Index declining 0.12%. Combined trading volume reached 1.24 trillion yuan in the first half of the day, up 79.5 billion yuan from the previous session. Innovative drug and CXO concept stocks rallied, with Jinshi Yaoye, Baihua Pharmaceutical, and Nanhua Biotech hitting daily limits, following GenScript Biotech's collaboration with Eli Lilly's AI drug discovery platform. Zheshang Securities noted that AI-driven drug discovery has moved from 'algorithmic narrative' to 'clinical realization.' The automotive sector saw sudden gains, with Ankai Bus and Haima Automobile hitting daily limits after GAC Group announced plans to acquire equity from FAW. Agricultural stocks like Jinjian Rice Industry and Dunhuang Seed also hit daily limits following a government action plan for digital villages. The tourism sector performed well amid a new cultural and tourism development plan. Key market news included Huawei's announcement that the Ascend 960 chip release is moved up to Q1 2027, and the Federal Reserve raising interest rates by 25 basis points to 3.75%-4.00%, the first hike since July 2023.
Read sourceChina Stocks Fluctuate Lower; Innovative Drugs Surge, Auto and Agriculture Active
Chinese stock markets experienced a volatile morning session on September 17, with all three major indices closing slightly lower despite an initial surge. The Shanghai Composite fell 0.36%, the Shenzhen Component fell 0.29%, and the ChiNext fell 0.12%. Combined turnover reached 1.24 trillion yuan, up 79.5 billion from the previous session. Sector rotation was rapid, with innovative drug and CXO concepts rallying broadly after GenScript Biotech announced a collaboration with Eli Lilly's AI drug discovery platform. The automotive sector saw sudden upward momentum following GAC Group's announcement of a planned equity acquisition from FAW Co., Ltd. Agriculture stocks were active after the release of a digital village development action plan. Tourism also performed well amid a new cultural and tourism five-year plan. Meanwhile, technology sector divergence re-emerged. In other news, Huawei's Wang Tao announced the Ascend 960 chip release has been moved up to Q1 2027, and the Federal Reserve raised interest rates by 25 basis points, the first hike since July 2023.
Read sourceChina Stocks Close Lower; Innovative Drug, Auto, Agriculture Sectors Active; Fed Hikes Rates
Chinese stock markets closed slightly lower on September 17 after a volatile morning session, with the Shanghai Composite Index falling 0.36%, the Shenzhen Component Index dropping 0.29%, and the ChiNext Index declining 0.12%. Combined trading volume reached 1.24 trillion yuan. The pharmaceutical sector remained strong, with Jinshi Yaoye, Baihua Pharmaceutical, and Nanhua Biotech hitting daily limit-ups, partly driven by GenScript Biotech's collaboration with Eli Lilly's AI drug discovery platform. Zheshang Securities noted AI-driven drug discovery has entered the 'clinical realization' phase. The automotive sector saw unusual upward movements following GAC Group's announcement of a strategic investment from FAW Co., Ltd. The agricultural sector was active after the release of a digital village action plan. The tourism sector also performed well. Meanwhile, the Federal Reserve raised interest rates by 25 basis points, the first hike since July 2023. Huawei announced the Ascend 960 chip release has been moved up to Q1 2027.
Read sourceChina Stocks End Morning Lower; Innovative Drugs, Auto, Agriculture Sectors Active
Chinese stock markets ended the morning session slightly lower on September 17, with the Shanghai Composite Index falling 0.36%, the Shenzhen Component Index dropping 0.29%, and the ChiNext Index declining 0.12%. Combined trading volume reached 1.24 trillion yuan, up 79.5 billion yuan from the previous session. Sector rotation was rapid, with innovative drug and CXO concept stocks surging after GenScript Biotech announced a collaboration with Eli Lilly's AI drug discovery platform. Zheshang Securities commented that AI-driven drug discovery has moved to the clinical realization phase. The automotive sector saw sudden gains following GAC Group's announcement of a planned equity acquisition from FAW Co., Ltd. The agriculture sector was active after China's Cyberspace Administration and other ministries issued a digital village development plan for 2026-2030. The tourism sector also performed well after the Ministry of Culture and Tourism released its 15th Five-Year Plan. Over 3,100 stocks declined, with precious metals concepts falling. The Federal Reserve raised interest rates by 25 basis points to 3.75%-4.00%, its first hike since July 2023.
Read source